Conference report: strategies for the regulation of homeopathic medicinal products
Jun 19, 2017
The report of the World Integrated Medicine Forum on the ‘Regulation of homoeopathic medicinal products: National and Global strategies’ has now been published in The Indian Journal of Research in Homoeopathy.
This two day conference, held in Delhi in February this year, brought together 50 delegates from 25 countries to discuss the current state of regulation of homoeopathic medicinal products. Participants included government officials, manufacturers, pharmacopoeia organisations, pharmacists, and healthcare providers worldwide; the forum had a specific focus on the value of harmonisation of pharmacopoeias and linking industry and regulators. The two-day meeting was organised with the support of the Indian Ministry of Ayurveda, Yoga, Unani, Siddha and Homoeopathy (AYUSH).
The Minister of AYUSH was the keynote speaker for the meeting. The core presentations delivered information on the country‑to‑country variance in regulatory requirements for homoeopathic medicine manufacture and marketing. Different speakers addressed the current pharmacopeia structures in various countries, variance in premarket approval process, regulatory frameworks for homoeopathic medicines, labelling requirements, safety requirements, marketing approaches and good manufacturing practices. Debates focused on quality control testing, stability of intermediate stocks, shelf life of finished products, pre‑market approval process and labelling and they shed light on regional differences in regulation. A lengthy discussion was held on the potential value of harmonisation of pharmacopoeias, manufacturing standards, safety evaluation and labelling.
The report compiles presentations from the eight interactive sessions and the panel discussion held on the second day. It also includes the recommendations made over the two days.
- Related content